Genzyme boosts Sanofi in Q1 but Plavix patent loss will erode FY earnings
This article was originally published in Scrip
Executive Summary
Sanofi's share price rose by up to 3.9% to €59.00 today after the company posted strong sales and earnings growth in the first quarter, casting a ray of sunshine in a generally gloomy earnings season for the pharma industry.